PillRx only · Tablet, Orally Disintegrating · Oral
Clozapine
Clozapine
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 17 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$10.016
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
5
Active US suppliers
75%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
8.6K
Rx · 2026 Q1
509K
Units dispensed
-19%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 9 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 9 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Mylan Institutional LLC | unknown | 1 | SUPPLYING |
| Safecor Health, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 21, 2018RECALLRecall (Class II): Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wal…
Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing. — Recalling firm: Teva Pharmaceuticals USA — Distributed nationwide in the USA